Literature DB >> 24117537

T cell suppression in vitro during Toxoplasma gondii infection is the result of IL-2 competition between Tregs and T cells leading to death of proliferating T cells.

N Salinas1, J E Olguín, C Castellanos, R Saavedra.   

Abstract

A reduced proliferation to T cell mitogens is observed in vitro in murine cells isolated during the acute phase of Toxoplasma gondii infection. Foxp3(+) regulatory T cells (Tregs) mediate this suppression, which is interleukin (IL)-2 dependent. In this work, we analysed the mechanism of this Treg-mediated suppression. We found that removal of antigen-presenting cells (APC) from spleen cells from infected mice did not modify suppression but further elimination of Tregs led to a restored proliferation, demonstrating that Tregs mediate suppression in the absence of APC. Production of IL-2 by T cells from infected animals was abolished but partially restored when Tregs were removed. However, IL-2 levels and T cell proliferation were restored when Tregs and T cells were separated by transwells, indicating that Tregs require close proximity with T cells to induce suppression. Tregs from infected mice were able to reduce proliferation of CTLL-2 cells in the classical IL-2 bioassay, strongly suggesting that Tregs compete with T cells for IL-2. We found that T cells from infected mice died after a few rounds of division in vitro, but addition of recombinant IL-2 or removal of Tregs abolished this effect. Our results showed that suppression of T cell proliferation during acute Toxoplasma gondii infection is the result of death of proliferating T cells by Treg-mediated IL-2 competition. Thus, immunosuppression is due to death of proliferating T cells as a consequence of low IL-2 availability.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24117537     DOI: 10.1111/sji.12120

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Spleen atrophy related immune system changes attributed to infection of Angiostrongylus cantonensis in mouse model.

Authors:  Zhen Liu; Yu Wu; Ying Feng; Feng Wu; Rui-Feng Liu; Li-Fu Wang; Jin-Yi Liang; Jia-Hua Liu; Xi Sun; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2016-11-22       Impact factor: 2.289

2.  Role of CD4+ Foxp3+ Regulatory T Cells in Protection Induced by a Live Attenuated, Replicating Type I Vaccine Strain of Toxoplasma gondii.

Authors:  Haroon Akbar; Isabelle Dimier-Poisson; Nathalie Moiré
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

3.  A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles.

Authors:  Ying Xu; Nian-Zhang Zhang; Meng Wang; Hu Dong; Sheng-Yong Feng; Hui-Chen Guo; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2015-08-06       Impact factor: 2.289

4.  Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.

Authors:  Christoph-Martin Ufermann; Andreas Domröse; Timo Babel; Anne Tersteegen; Sevgi Can Cengiz; Silvia Kathrin Eller; Katrin Spekker-Bosker; Ursula Regina Sorg; Irmgard Förster; Walter Däubener
Journal:  Front Cell Infect Microbiol       Date:  2019-06-05       Impact factor: 5.293

Review 5.  Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.

Authors:  Madiha Sana; Muhammad Rashid; Imran Rashid; Haroon Akbar; Jorge E Gomez-Marin; Isabelle Dimier-Poisson
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

6.  Mixed lymphocyte reaction induced by multiple alloantigens and the role for IL-10 in proliferation inhibition.

Authors:  Junyi Zhou; Weifeng He; Gaoxing Luo; Jun Wu
Journal:  Burns Trauma       Date:  2014-01-26

7.  Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells.

Authors:  Andreas Kupz; Saparna Pai; Paul R Giacomin; Jennifer A Whan; Robert A Walker; Pierre-Mehdi Hammoudi; Nicholas C Smith; Catherine M Miller
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.